News

Convenient sound bites do not take the place of true intelligence.

Will the 34 federally-facilitated and state-partnership exchange programs be sufficient?

Managed care organizations will be remiss if they don’t seriously consider the evolving competitive landscape.

New network designs drive quality through data sharing

Consumers need in-person assistance to understand the health law and what it means to them

While HHS touts big savings for consumers, insurers feel the pinch on prices

Employers are threatening to cut hours and workers to avoid PPACA requirements

Pharmacy leaders say benchmark plans too limited and PPACA too prescriptive

A global Accenture study shows patients want access to EMRs so they can get more involved in their care

Stakeholders weigh the pros and cons of convenient care clinics found in drug stores and grocery outlets

Young invincibles who are used to their parents' plans will no doubt want to continue coverage

The significance and impact of the primary care physician shortage is evaluated by industry experts.

A key initiative for Seaside Health Plan is California Children’s Services demo

Families USA drills down to estimate the number of subsidized enrollees

Digoxin, commonly used to treat heart conditions, was associated with a 72% higher rate of death among adults with newly diagnosed heart failure, according to a Kaiser Permanente study in the September issue of Circulation: Cardiovascular Quality and Outcomes.

In adult patients with type 2 diabetes mellitus (T2DM) who are uncontrolled on metformin and sulfonylurea, dapagliflozin can be added to help improve HbA1c and reduce fasting plasma glucose, body weight, and seated systolic blood pressure, according to results from a study presented at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain, in September.

A new study may set a new standard for the treatment of venous thromboembolism (VTE) with a single oral anticoagulant.

Cognitive enhancers-drugs taken to enhance concentration, memory, alertness, and moods- that are often given to patients with Alzheimer’s disease do not improve cognition or function for those with mild cognitive impairment (MCI) in the long term-about 96 weeks, according to a study published recently in the Canadian Medical Association Journal.

A new report by the US Centers for Disease Control and Prevention (CDC) says millions of Americans are at risk from drug-resistant superbugs that cause gonorrhea, C. difficile, and carbapenem-resistant Enterobacteriaceae (CRE).

FDA is requiring color changes to the printing on fentanyl (Duragesic) pain patches so that it is clearly visible, to help avoid risk of accidental exposure. Accidental exposure to these patches that contain a narcotic opioid can cause serious harm and death in children, pets, and others.

Tamoxifen use among some women with breast cancer has been reported to cause mental “fogginess” while on the medication, and researchers have demonstrated that the side effect is real, according to an online study published Sept. 17 in the Journal of Neuroscience.

Physicians discussed sunscreen use with patients at less than 1 percent of visits, according to recent study results.

About half of smokers seeking treatment for smoking cessation have a history of depression. Compared with smokers who are not depressed, those who suffer from a major depressive disorder (MDD) have greater difficulty quitting, according to a study published September 17 in the Annals of Internal Medicine.

In order to help combat the national prescription drug abuse epidemic, CVS Caremark is tapping its extensive database to identify and halt inappropriate prescribing of high-risk drugs such as opioid painkillers.

Filling a prescription at a doctor’s office may be convenient, but it’s certainly no bargain for patients or taxpayers, according to an analysis of workers’ compensation payouts in Maryland and Pennsylvania.

Video contest aims to raise awareness about health reform and encourage young people to take advantage of the benefits of health insurance.

In hopes of decreasing opioid abuse, addictions, and overdose deaths, FDA this week announced safety-labeling changes for all extended-release and long-acting (ER/LA) opioid analgesics used to treat pain. FDA has also added new postmarket study requirements for opioids such as morphine, oxycodone, and fentanyl.